News – Page 1068 – Endpoints News

Cancer drug to treat dwarfism? Abandoned Novartis asset snagged by BridgeBio’s QED Therapeutics

8 years ago

Corbus Pharma reels in $25M to pay for its PhIIb cystic fibrosis study, shares sink

8 years ago

After a legendary stint at Celgene's helm, biopharma vet Bob Hugin is on his way out — as Senate race rumors swirl

8 years ago

Roche touts CHMP nod for Hemlibra; Alder raises $200M for migraine drug launch

8 years ago

Merck spinout grabs some assets and launches a quest for the Holy Grail in antibiotics R&D

8 years ago

Suspicious returns trigger insider trading suit following $11.6B Bioverativ deal

8 years ago

Roche scores an unusual ‘breakthrough’ at the FDA for an autism drug

8 years ago

Aradigm completes disastrous regulatory run as FDA slaps down Linhaliq application

8 years ago

Sorry Novo: Sanofi wins Ablynx over with $4.8B buyout bid, bagging nanobody platform tech

8 years ago

In post-IPO party, Nasdaq’s newcomers Armo, Menlo and Solid soar within hours of listing

8 years ago

Novartis scores a quick FDA OK for its new cancer drug Lutathera, picked up in $4B buyout

8 years ago

Vas Narasimhan joins the power circle at Davos; Armo Bio, resTORbio raises $128M and $85M in IPO

8 years ago

Heptares co-founder Fiona Marshall to lead Merck's London research hub; Ablynx appoints Robert Friesen as new CFO

8 years ago

Ex-Merrimack CEO Mulroy launches oncology startup Partner Therapeutics

8 years ago

When will Biogen finally pull the trigger on a blockbuster M&A deal?

8 years ago

Behind the deal spree, Celgene continues to cautiously explore neurosciences

8 years ago

Under pressure to perform, Woodford counterattacks against Sahm Adrangi's latest short assault

8 years ago

Trailing GSK, AstraZeneca offers an encouraging look at PhIII data for three-in-one COPD inhaler

8 years ago

Fast-growing Shanghai Pharma to plant foot in San Diego, hunting deals in US and Europe

8 years ago

Duchenne MD dad pivots from last-minute alert on FDA's partial hold to $125M IPO for Solid Bio

8 years ago

Summit shares shoot up on positive DMD PhII; AstraZeneca and allies back a new incubator/accelerator at Babraham

8 years ago

Women’s health biotech KaNDy dickering with Allergan about a $400M buyout deal — report

8 years ago

Menlo bags $119M IPO on promise of ex-Merck drug

8 years ago

Takeda and Zinfandel write off yet another Alzheimer’s PhIII after Actos fails a key interim test

8 years ago

First page Previous page 1065 1066 106710681069 1070 1071 Next page Last page